BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15454300)

  • 1. Approaches to determine the enthalpy of crystallisation, and amorphous content, of lactose from isothermal calorimetric data.
    Dilworth SE; Buckton G; Gaisford S; Ramos R
    Int J Pharm; 2004 Oct; 284(1-2):83-94. PubMed ID: 15454300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calorimetric determination of amorphous content in lactose: a note on the preparation of calibration curves.
    Ramos R; Gaisford S; Buckton G
    Int J Pharm; 2005 Aug; 300(1-2):13-21. PubMed ID: 16009516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
    Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
    Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of high speed DSC (hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples.
    Saunders M; Podluii K; Shergill S; Buckton G; Royall P
    Int J Pharm; 2004 Apr; 274(1-2):35-40. PubMed ID: 15072780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the critical relative humidity for moisture-induced phase transitions.
    Burnett DJ; Thielmann F; Booth J
    Int J Pharm; 2004 Dec; 287(1-2):123-33. PubMed ID: 15541919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moisture sorption, compressibility and caking of lactose polymorphs.
    Listiohadi Y; Hourigan JA; Sleigh RW; Steele RJ
    Int J Pharm; 2008 Jul; 359(1-2):123-34. PubMed ID: 18485633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An X-ray diffraction analysis of crystallised whey and whey-permeate powders.
    Nijdam J; Ibach A; Eichhorn K; Kind M
    Carbohydr Res; 2007 Nov; 342(16):2354-64. PubMed ID: 17719020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of inverse gas chromatography and gravimetric vapour sorption to study transitions in amorphous lactose.
    Ambarkhane AV; Pincott K; Buckton G
    Int J Pharm; 2005 Apr; 294(1-2):129-35. PubMed ID: 15814237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization and X-ray diffraction of spray-dried and freeze-dried amorphous lactose.
    Haque MK; Roos YH
    Carbohydr Res; 2005 Feb; 340(2):293-301. PubMed ID: 15639249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of amorphous content on compaction behaviour of anhydrous alpha-lactose.
    Ziffels S; Steckel H
    Int J Pharm; 2010 Mar; 387(1-2):71-8. PubMed ID: 20005927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
    Vollenbroek J; Hebbink GA; Ziffels S; Steckel H
    Int J Pharm; 2010 Aug; 395(1-2):62-70. PubMed ID: 20493937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of amorphous content of lactose using CCD-Raman spectroscopy.
    Niemelä P; Päällysaho M; Harjunen P; Koivisto M; Lehto VP; Suhonen J; Järvinen K
    J Pharm Biomed Anal; 2005 Apr; 37(5):907-11. PubMed ID: 15862665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of heat of adsorption to quantify amorphous content in milled pharmaceutical powders.
    Alam S; Omar M; Gaisford S
    Int J Pharm; 2014 Jan; 459(1-2):19-22. PubMed ID: 24315924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quantification of small degrees of disorder in lactose using solution calorimetry.
    Hogan SE; Buckton G
    Int J Pharm; 2000 Oct; 207(1-2):57-64. PubMed ID: 11036230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the moisture-induced crystallization kinetics of spray-dried lactose.
    Burnett DJ; Thielmann F; Sokoloski T; Brum J
    Int J Pharm; 2006 Apr; 313(1-2):23-8. PubMed ID: 16466870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of inverse phase gas chromatography to study the change of surface energy of amorphous lactose as a function of relative humidity and the processes of collapse and crystallisation.
    Newell HE; Buckton G; Butler DA; Thielmann F; Williams DR
    Int J Pharm; 2001 Apr; 217(1-2):45-56. PubMed ID: 11292541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring crystallisation of drugs from fast-dissolving oral films with isothermal calorimetry.
    Gaisford S; Verma A; Saunders M; Royall PG
    Int J Pharm; 2009 Oct; 380(1-2):105-11. PubMed ID: 19596058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization and X-ray diffraction of crystals formed in water-plasticized amorphous lactose.
    Jouppila K; Kansikas J; Roos YH
    Biotechnol Prog; 1998; 14(2):347-50. PubMed ID: 9548791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of lactose crystallinity using Raman spectroscopy.
    Murphy BM; Prescott SW; Larson I
    J Pharm Biomed Anal; 2005 Jun; 38(1):186-90. PubMed ID: 15907639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.